Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Replimune Group, Inc. Grants Inducement Equity Awards to Newly Hired Non-Executive Employees
Oct 10, 2024
Contract Type
agreement
WoburnBiotechnologyHealth Care
Description
Replimune Group, Inc. announced the grant of inducement equity awards to 9 newly hired non-executive employees in the form of non-qualified stock options and restricted stock units. The awards were approved by the compensation committee of the Company's board of directors in reliance on the employment inducement exception under Nasdaq Listing Rule 5635(c)(4).
Company Information
Company
Replimune
Location
Woburn, Massachusetts, United States
About
Replimune is working to advance the science of oncolytic immunotherapy to improve on existing therapies and help treat more patients with a variety of tumor types. Oncolytic immunotherapy uses viruses that have been modified to selectively replicate in and kill tumors.
Replimunes' goal is to develop powerful therapies to overcome cancer.